InsidersTradesSigma
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Agah Ramtin, Directeur Médical. Insider active across 1 company, notably RenovoRx, Inc.. In total, 9 disclosures have been logged. Split: 6 buys · 0 sell. Total volume traded: €94k. Activity tracked since 16 March 2022. The latest transaction was disclosed on 5 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Ramtin Agah is the Chief Medical Officer at RenovoRx, Inc. He is responsible for overseeing the company's medical and research initiatives. With extensive expertise in the medical field, he plays a key role in developing new therapies and improving patient outcomes. His leadership helps position RenovoRx as a leader in the healthcare sector.